Stocks and Investing
Stocks and Investing
Fri, April 3, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Arlinda Lee Reiterated (BNTX) at Strong Buy with Increased Target to $60 on, Apr 3rd, 2020
Arlinda Lee of Canaccord Genuity, Reiterated "BioNTech SE" (BNTX) at Strong Buy with Increased Target from $22 to $60 on, Apr 3rd, 2020.
Arlinda has made no other calls on BNTX in the last 4 months.
There are 4 other peers that have a rating on BNTX. Out of the 4 peers that are also analyzing BNTX, all agree with Arlinda's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Cory Kasimov of "JP Morgan" Downgraded from Buy to Hold and Held Target at $33 on, Wednesday, March 18th, 2020
- Robert Burns of "HC Wainwright & Co." Initiated at Hold and Held Target at $30 on, Monday, March 9th, 2020
- Daina Graybosch of "SVB Leerink" Downgraded from Buy to Hold and Increased Target to $31 on, Friday, January 24th, 2020
- Eliana Merle of "UBS" Downgraded from Strong Buy to Hold and Increased Target to $35 on, Wednesday, January 22nd, 2020